Use of gellable pharmaceutical compositions in periodontology
AssigneeUcb, S.A.
InventorsDomenico Fanara, Henri Vranckx, Michel Deleers, Pierre Grognet
Life of this patent
Estimating the term…
Abstract
The invention concerns the use for treating periodontitis of a fluid pharmaceutical composition for controlled release of at least one active substance comprising: a) a therapeutically efficient amount of at least an active substance; b) 3 to 55 wt. % of phospholipid; c) 16 to 72 wt. % of one or several pharmaceutically acceptable solvents; and d) 4 to 52 wt. % of at least one fatty acid. Said composition is characterised in that it has the property of being gelled instantaneously in the presence of an aqueous phase.
Claims20
Use of a fluid pharmaceutical composition which allows the controlled release of at least one active substance and which comprises
- a) a therapeutically effective amount of at least one active substance,
- b) from 3 to 55% by weight of phospholipid,
- c) from 16 to 72% by weight of pharmaceutically acceptable solvent, and
- d) from 4 to 52% by weight of fatty acid, said composition having the property of gelling instantaneously in the presence of an aqueous phase, for preparing a medicinal product intended for treating a person or an animal suffering from periodontitis.
Use of a fluid pharmaceutical composition which allows the controlled release of at least one active substance and which comprises
- a) a therapeutically effective amount of at least one active substance,
- b) from 3 to 55% by weight of phospholipid,
- c) from 16 to 72% by weight of pharmaceutically acceptable solvent, and
- d) from 4 to 52% by weight of fatty acid, said composition having the property of gelling instantaneously in the presence of an aqueous phase, for treating a person or an animal suffering from periodontitis, characterized in that the composition is applied into one or more periodontal pockets.
Dependencies are inferred from the claim text.